title: Hippocampal GluA1-containing AMPA receptors mediate context-dependent sensitization to morphine.
abstract: Glutamatergic systems, including AMPA receptors (AMPARs), are involved in opiate-induced neuronal and behavioral plasticity, although the mechanisms underlying these effects are not fully understood. In the present study, we investigated the effects of repeated morphine administration on AMPAR expression, synaptic plasticity, and context-dependent behavioral sensitization to morphine. We found that morphine treatment produced changes of synaptic AMPAR expression in the hippocampus, a brain area that is critically involved in learning and memory. These changes could be observed 1 week after the treatment, but only when mice developed context-dependent behavioral sensitization to morphine in which morphine treatment was associated with drug administration environment. Context-dependent behavioral sensitization to morphine was also associated with increased basal synaptic transmission and disrupted hippocampal long-term potentiation (LTP), whereas these effects were less robust when morphine administration was not paired with the drug administration environment. Interestingly, some effects may be related to the prior history of morphine exposure in the drug-associated environment, since alterations of AMPAR expression, basal synaptic transmission, and LTP were observed in mice that received a saline challenge 1 week after discontinuation of morphine treatment. Furthermore, we demonstrated that phosphorylation of GluA1 AMPAR subunit plays a critical role in the acquisition and expression of context-dependent behavioral sensitization, as this behavior is blocked by a viral vector that disrupts GluA1 phosphorylation. These data provide evidence that glutamatergic signaling in the hippocampus plays an important role in context-dependent sensitization to morphine and supports further investigation of glutamate-based strategies for treating opiate addiction.
authors.affiliation: Department of Anesthesiology, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.
authors.forename: Yan
authors.initials: Y
authors.lastname: Xia
authors.forename: George S
authors.initials: GS
authors.lastname: Portugal
authors.forename: Amanda K
authors.initials: AK
authors.lastname: Fakira
authors.forename: Zara
authors.initials: Z
authors.lastname: Melyan
authors.forename: Rachael
authors.initials: R
authors.lastname: Neve
authors.forename: H Thomas
authors.initials: HT
authors.lastname: Lee
authors.forename: Scott J
authors.initials: SJ
authors.lastname: Russo
authors.forename: Jie
authors.initials: J
authors.lastname: Liu
authors.forename: Jose A
authors.initials: JA
authors.lastname: Morón
mesh_terms: D000409:Alanine / Q000235:genetics; D000704:Analysis of Variance; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D002352:Carrier Proteins / Q000378:metabolism; D018797:Cell Cycle Proteins; D000076122:Disks Large Homolog 4 Protein; D004305:Dose-Response Relationship, Drug; D019706:Excitatory Postsynaptic Potentials / Q000187:drug effects; D018014:Gene Transfer Techniques; D049452:Green Fluorescent Proteins / Q000235:genetics; D051528:Guanylate Kinases / Q000378:metabolism; D006624:Hippocampus / Q000187:drug effects*; D020287:In Situ Nick-End Labeling / Q000379:methods; D017774:Long-Term Potentiation / Q000187:drug effects; D008297:Male; D008565:Membrane Proteins / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D009020:Morphine / Q000494:pharmacology*; D009021:Morphine Dependence / Q000378:metabolism*; D009043:Motor Activity / Q000187:drug effects*; D009154:Mutation / Q000235:genetics; D009294:Narcotics / Q000494:pharmacology*; D009687:Nuclear Proteins / Q000378:metabolism; D010766:Phosphorylation / Q000187:drug effects; D021381:Protein Transport / Q000187:drug effects; D011897:Random Allocation; D018091:Receptors, AMPA / Q000235:genetics / Q000378:metabolism*; D012694:Serine / Q000235:genetics; D013347:Subcellular Fractions / Q000187:drug effects / Q000378:metabolism
chemical_list: D000409:Alanine; D002352:Carrier Proteins; D018797:Cell Cycle Proteins; D000076122:Disks Large Homolog 4 Protein; D049452:Green Fluorescent Proteins; D051528:Guanylate Kinases; D008565:Membrane Proteins; D009020:Morphine; D009294:Narcotics; D009687:Nuclear Proteins; D018091:Receptors, AMPA; D012694:Serine; C501447:Dlg4 protein, mouse; C091822:Prkcabp protein, mouse; C104722:glutamate receptor ionotropic, AMPA 2
references.citation: Eur J Neurosci. 2009 Jan;29(1):55-64
references.pmid: 19077125
references.citation: J Neurosci. 2005 Oct 5;25(40):9144-51
references.pmid: 16207873
references.citation: Proc Natl Acad Sci U S A. 1982 Dec;79(23):7590-4
references.pmid: 6760199
references.citation: Am J Physiol Renal Physiol. 2004 Feb;286(2):F298-306
references.pmid: 14600029
references.citation: J Neurochem. 2010 Apr;113(1):42-53
references.pmid: 19968761
references.citation: Neuroscience. 2009 Mar 3;159(1):414-26
references.pmid: 19105975
references.citation: J Neurosci. 2007 Jul 25;27(30):7921-8
references.pmid: 17652583
references.citation: J Neurophysiol. 2008 Jul;100(1):533-8
references.pmid: 18450581
references.citation: J Neurosci. 2002 Jan 15;22(2):389-95
references.pmid: 11784783
references.citation: Eur J Neurosci. 2010 Jul;32(2):261-8
references.pmid: 20946114
references.citation: Neurosignals. 2006-2007;15(5):266-82
references.pmid: 17622793
references.citation: Behav Neurosci. 2006 Apr;120(2):401-12
references.pmid: 16719704
references.citation: J Neurosci. 2000 Mar 1;20(5):RC62
references.pmid: 10684909
references.citation: Trends Neurosci. 2010 May;33(5):241-8
references.pmid: 20219255
references.citation: Behav Brain Res. 2011 Jan 1;216(1):321-31
references.pmid: 20727914
references.citation: Mol Neurobiol. 2005 Dec;32(3):237-49
references.pmid: 16385140
references.citation: J Neurosci. 2006 Oct 25;26(43):11041-51
references.pmid: 17065446
references.citation: Philos Trans R Soc Lond B Biol Sci. 2008 Oct 12;363(1507):3233-43
references.pmid: 18640922
references.citation: Eur J Neurosci. 2001 Nov;14(9):1533-8
references.pmid: 11722615
references.citation: Trends Neurosci. 2010 Jun;33(6):267-76
references.pmid: 20207024
references.citation: Neuropsychopharmacology. 2010 Dec;35(13):2579-89
references.pmid: 20811341
references.citation: Mol Pharmacol. 2010 May;77(5):874-83
references.pmid: 20159947
references.citation: J Neurosci. 2007 Sep 26;27(39):10621-35
references.pmid: 17898233
references.citation: Curr Opin Pharmacol. 2005 Feb;5(1):9-19
references.pmid: 15661620
references.citation: Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11435-40
references.pmid: 12165570
references.citation: Nat Neurosci. 2008 Sep;11(9):1053-8
references.pmid: 19160503
references.citation: Mol Cell Proteomics. 2007 Jan;6(1):29-42
references.pmid: 17028301
references.citation: Science. 2001 May 11;292(5519):1175-8
references.pmid: 11349151
references.citation: Nat Neurosci. 2011 Apr;14(4):420-2
references.pmid: 21336273
references.citation: J Neurosci. 2011 May 25;31(21):7927-37
references.pmid: 21613507
references.citation: Neuropsychopharmacology. 2010 Feb;35(3):818-33
references.pmid: 19924109
references.citation: J Biol Chem. 2002 Apr 5;277(14):12359-63
references.pmid: 11805122
references.citation: J Neurosci. 2006 Mar 1;26(9):2544-54
references.pmid: 16510732
references.citation: Neuropharmacology. 2008 Aug;55(2):230-7
references.pmid: 18614186
references.citation: Nature. 2000 Jun 22;405(6789):955-9
references.pmid: 10879537
references.citation: J Neurosci. 2004 Jul 7;24(27):6152-60
references.pmid: 15240807
references.citation: Nature. 2008 Jul 3;454(7200):118-21
references.pmid: 18500330
references.citation: J Neurosci. 2002 Mar 1;22(5):1914-21
references.pmid: 11880521
references.citation: Eur Neuropsychopharmacol. 2011 Nov;21(11):825-34
references.pmid: 21277174
references.citation: Neuropharmacology. 2004;47 Suppl 1:61-79
references.pmid: 15464126
references.citation: Nat Neurosci. 2009 Aug;12(8):1069-73
references.pmid: 19620976
references.citation: J Neurosci. 2011 Jan 5;31(1):314-21
references.pmid: 21209217
references.citation: J Neurosci. 1997 Jan 1;17(1):58-69
references.pmid: 8987736
references.citation: Neuron. 2000 Nov;28(2):511-25
references.pmid: 11144360
references.citation: Nature. 2001 May 31;411(6837):583-7
references.pmid: 11385572
references.citation: Neuron. 2000 Mar;25(3):649-62
references.pmid: 10774732
references.citation: Brain Res Brain Res Rev. 1993 Sep-Dec;18(3):247-91
references.pmid: 8401595
references.citation: Neuron. 2000 Jul;27(1):107-19
references.pmid: 10939335
references.citation: Neuropsychopharmacology. 2010 Mar;35(4):955-66
references.pmid: 19956087
references.citation: Neuron. 1996 Jun;16(6):1179-88
references.pmid: 8663994
references.citation: Nature. 2000 Dec 21-28;408(6815):936-43
references.pmid: 11140673